Providence Brain and Spine Institute
Diana Moses R.N., C.N.S., M.S., C.N.R.N.; Mark Yerby M.D., M.P.H., F.A.A.N., James Schimshock M.D.
Providence Epilepsy Services, Portland, Oregon
Vagal nerve stimulation (VNS) is an adjunctive therapy for improving seizure control in patients with epilepsy. The actual mechanism for how the VNS prevents seizures is not precisely known.
More »View current clinical trials investigating treatments for ALS.
More »View current clinical trials investigating treatments for Alzheimer’s disease. More »
Useful therapies are available for virtually every patient with multiple sclerosis. FDA-approved medications currently in use have had major beneficial impact on disease activity in many patients, but we must do better. We must develop therapies with even more potency in disease control, less potential of toxicity and improved ease of administration and patient comfort. More »
View current clinical trials investigating treatments for stroke. More »
More »
Thrombolytic or "clot-busting" drugs offer an emergency treatment option for some people who are having a stroke. These medications, which include an agent called a tissue plasminogen activator (t-PA), halt the stroke by dissolving the blood clot that is blocking blood flow to the brain. More »
Although controlled clinical trials have established the efficacy of IFNB for the treatment of RMS, most studies are of comparatively short duration. Other long-term open-label extensions are often compromised by high attrition and incomplete clinical information. Further-more, few studies have evaluated long-term efficacy of IFNB in a large community-based cohort of RMS patients. More »
Purpose of study: To determine if Nuedexta exerts a palliative effect on speech, swallowing and salivation in patients with ALS.
Principal Investigator: Dr. Kimberly Goslin
Contact: Providence ALS Research Nurse at 503 962-1171
Sponsor: ALS Association (ALSA) and the Northeast ALS Consortium (NEALS) More »
Accurate measures of MS prevalence in the Pacific Northwest United States were lacking. The Pacific Northwest MS Registry was established by the Providence MS Center and the National MS Society Oregon Chapter in 2007 to assess geographic distribution, access to medical care and treatment for MS, as well as unique characteristics of the MS population in this region. More »
More »